Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-26-096746·Damora Therapeutics, Inc.
Schedule 13G ownership disclosure
GALECTO INC
Common Stock, $0.00001 par value per share · CUSIP: 36322Q107
Event date: 2026-02-28
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ikarian Capital, LLC
Shares: 335,710 · Class: 0.6%
- Neil Shahrestani
Shares: 335,710 · Class: 0.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-096746
- Form type
- SCHEDULE 13G/A
- Filer
- Damora Therapeutics, Inc.
- CIK
- CIK 1800315
- Filed
- Mar 06, 2026
- Reporting period
- Feb 28, 2026
- Description
- Schedule 13G beneficial ownership